Ani Pharmaceuticals (ANIP) Accounts Payables (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Accounts Payables of $69.7 million for Q1 2026, up 11.36% sequentially from $62.6 million in Q4 2025, and up 31.35% YoY from $53.1 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Accounts Payables (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Accounts Payables for 17 years, with the latest figure at $69.7 million in Q1 2026.
- Quarterly Accounts Payables rose 31.35% year-over-year to $69.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.7 million (up 31.35% YoY) and the FY2025 annual result came in at $62.6 million, up 37.08% from the prior year.
- Accounts Payables improved to $69.7 million in Q1 2026 per ANIP's latest filing, from $62.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $69.8 million in Q3 2025 and troughed at $19.0 million in Q3 2022.
- A 5-year average of $43.8 million and a median of $45.7 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables soared 113.0% in 2022, then grew 3.13% in 2023.
- Over 5 years, Accounts Payables stood at $29.3 million in 2022, then increased by 25.18% to $36.7 million in 2023, then climbed by 24.46% to $45.7 million in 2024, then soared by 37.08% to $62.6 million in 2025, then gained by 11.36% to $69.7 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $69.7 million, $62.6 million, and $69.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 73.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.83 Mn |
| Mar 31, 2026 | 69.69 Mn |
| Dec 31, 2025 | 62.58 Mn |
| Sep 30, 2025 | 69.80 Mn |
| Jun 30, 2025 | 54.57 Mn |
| Mar 31, 2025 | 53.06 Mn |
| Dec 31, 2024 | 45.66 Mn |
| Sep 30, 2024 | 60.89 Mn |
| Jun 30, 2024 | 48.68 Mn |
| Mar 31, 2024 | 49.43 Mn |
| Dec 31, 2023 | 36.68 Mn |
| Sep 30, 2023 | 34.08 Mn |
| Jun 30, 2023 | 28.51 Mn |
| Mar 31, 2023 | 32.69 Mn |
| Dec 31, 2022 | 29.31 Mn |
| Sep 30, 2022 | 18.99 Mn |
| Jun 30, 2022 | 27.64 Mn |
| Mar 31, 2022 | 22.06 Mn |
| Dec 31, 2021 | 22.97 Mn |
| Sep 30, 2021 | 11.51 Mn |